BioNTech's Covid Vaccine Expected to Generate $11 Billion in Revenue
BioNTech feels like a household name, but it's still an early-stage biotech. The price of rhodium is on the rise. And the International Monetary Fund and World Bank's spring meetings go virtual. Host: Nicholas Jasinski. Producer: Katie Ferguson.